Paid Clinical Trials in Myrtle Beach, SC
As of August 2026, 77 paid clinical trials are recruiting in Myrtle Beach, South Carolina. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Myrtle Beach offers studies at sites including Carolina Urologic Research Center for conditions such as Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Non-muscle Invasive Bladder Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Myrtle Beach
Trials by drug in Myrtle Beach
Filter results
Newly added in Myrtle Beach
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
74 clinical trials
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
The CONFORM Pivotal Trial
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
The ArtixASCEND Study
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Study of HLD-0915 in Patients With Metastatic Prostate Cancer
Top Research Study Locations in Myrtle Beach
Researchers run research studies in Myrtle Beach, SC at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Carolina Urologic Research Center | Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Prostate Cancer (Adenocarcinoma) | 30 |
| Carolina Urologic Research Center, LLC | Non-muscle Invasive Bladder Cancer, Prostate Cancer, Advanced Renal Cell Carcinoma | 12 |
| Parkway Surgery Center | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Cancer of the Prostate | 6 |
| Grand Strand Medical Center | Acute Lower Limb Arterial Occlusion, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma | 5 |
| START Carolinas | Bladder (Urothelial, Transitional Cell) Cancer, Metastatic Castration Resistant Prostate Cancer, NMIBC | 3 |
| Trial Management Associates | Clostridioides Difficile Associated Disease, Obesity, Obesity or Overweight | 3 |
| AUC Urologists, LLC | Metastatic Castration-Resistant Prostate Cancer, Non-muscle Invasive Bladder Cancer | 2 |
| Atlantic Urology Specialists | Carcinoma of the Prostate, Diagnostic Imaging, Elevated PSA | 2 |
| AMR Clinical South Strand, South Carolina | Hidradenitis Suppurativa | 1 |
| Avenzo Therapeutics Recruiting Site | Locally Advanced, Metastatic Solid Tumors, Solid Tumor Cancer | 1 |
| Carolina Regional Cancer Center | Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 | 1 |
| Carolina Urologic Research Center, the START Center for Cancer Research | Metastatic Castration-Resistant Prostate Cancer Patients, Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC | 1 |
| Coastal Eye Group | Non-muscle Invasive Bladder Cancer | 1 |
| Exelixis Clinical | Clear Cell Renal Cell Carcinoma (ccRCC), Colorectal Cancer (CRC), Drug-Drug Interaction (DDI) | 1 |
| GSK Investigational Site | Neoplasms | 1 |
| HCA Grand Strand | Atrial Fibrillation, Stroke | 1 |
| NEO-811 South Carolina Site | Clear Cell Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Metastatic, Kidney Cancer Metastatic | 1 |
| OrthoSC | Degenerative Disc Disease | 1 |
| START - Carolinas | Bladder (Urothelial, Transitional Cell) Cancer, Non-Muscle Invasive Bladder Carcinoma, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ | 1 |
| Site 02-006 - Carolina Urologic Research Center | Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG | 1 |
| South Texas Accelerated Research Therapeutics - Carolinas | Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | 1 |
| TMA Headlands LLC (d/b/a Trial Management Associates) | Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases | 1 |
| TMA Headlands LLC | Hypothyroidism | 1 |
| Trial Management Associates, LLC | Clostridioides Difficile Associated Disease | 1 |
| Vanda Investigational Site | Insomnia Disorder | 1 |
Active & Upcoming Studies in Myrtle Beach (2026)
Recruiting trials in Myrtle Beach grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (55 active studies)
- A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC · Phase 1 · UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd.
- An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC · Phase 3 · AstraZeneca
Diabetes & metabolic (5 active studies)
- A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin · Phase 3 · AstraZeneca
- A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus · Phase 3 · AstraZeneca
Neurology & pain (1 active study)
- The CONFORM Pivotal Trial · Conformal Medical, Inc
Cardiovascular (1 active study)
- The CONFORM Pivotal Trial · Conformal Medical, Inc
Common conditions studied in Myrtle Beach
- Prostate Cancer (12 active studies)
- Metastatic Castration-Resistant Prostate Cancer (4 active studies)
- Metastatic Castration-resistant Prostate Cancer (4 active studies)
- Non-muscle Invasive Bladder Cancer (3 active studies)
- Non-muscle Invasive Bladder Cancer With Carcinoma in Situ (3 active studies)
- Prostate Cancer (Adenocarcinoma) (3 active studies)
Leading research sponsors in Myrtle Beach
- AstraZeneca
- Pfizer
- Novartis Pharmaceuticals
- Janssen Research & Development, LLC
- Astellas Pharma Global Development, Inc.
Frequently asked questions
How many paid clinical trials are currently recruiting in Myrtle Beach?
There are approximately 77 recruiting clinical trials in Myrtle Beach, South Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Myrtle Beach pay participants?
Most recruiting trials in Myrtle Beach compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Myrtle Beach?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Myrtle Beach?
The most common conditions under active study in Myrtle Beach include Prostate Cancer (12), Metastatic Castration-Resistant Prostate Cancer (4), Metastatic Castration-resistant Prostate Cancer (4), Non-muscle Invasive Bladder Cancer (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Myrtle Beach?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Myrtle Beach on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Myrtle Beach?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Myrtle Beach?
Recruiting research sites in Myrtle Beach include Carolina Urologic Research Center, Carolina Urologic Research Center, LLC, Parkway Surgery Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Myrtle Beach right now?
The largest active categories in Myrtle Beach are Cancer & tumors (55), Diabetes & metabolic (5), Neurology & pain (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.